Anti-NMDA receptor (NMDAR)-specific chimeric autoantibody receptor T cells recognized a large panel of human patient-derived autoantibodies, released effector molecules, proliferated, and selectively killed antigen-specific target cell lines even in the presence of high autoantibody concentrations.
[Cell]